Advertisement
Screener

CVRx, Inc. (CVRX) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent

CVRx, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent

CVRx, Inc. (CVRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-13

  • CVRx, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -1.90%.
  • CVRx, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -1.50%.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month
2025-12-31-1.90%
10-K · filed 2026-02-13
2024-12-31-1.50%
10-K · filed 2026-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarioHealth Corp. (DRIO)$0.066B-1.39
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02